Medical experts will discuss advances in Alzheimer’s research at the eleventh annual Markesbery Symposium sponsored by the University of Kentucky.

Dr. Allan Levy, Professor and Chairman of the Department of Neurology at Emory University, is the keynote speaker at the Markesbery Symposium on Aging and Dementia.

The event will be held from 9-11:30 a.m., Saturday, November 20th via Zoom.

Register for this program at to obtain Zoom link.

Levy is Director of the Emory Alzheimer’s Disease Research Center. He has secondary faculty appointments in the Departments of Pharmacology and Psychiatry and Behavioral Sciences. He received a Bachelor of Science from the University of Michigan and an MD and PhD (Immunology) from the University of Chicago.

He then trained in Neurology at Johns Hopkins, molecular biology at the National Institutes of Health, and then joined the Johns Hopkins faculty in the Departments of Neurology & Pathology.

Levy has been at Emory University since 1991. He is a neurologist and neuroscientist internationally recognized for his work in neurodegenerative disease.

His work has contributed to understanding the brain systems and mechanisms involved in neurodegenerative disorders including Alzheimer’s and Parkinson’s diseases and in identifying molecular targets for new therapeutic strategies.

Also featured at this year’s Markesbury Symposium is discussion on Aducanamab/Aduhelm: the controversial new treatment for Alzheimer’s Disease. Dr. Gregory Jicha, Clinical Core Director, University of Kentucky Alzheimer’s Disease Research Center; Professor of Neurology and Dr. Erin Abner, Co-Director, Data Management and Statistics Core, University of Kentucky ADRC; Professor of Epidemiology will explain the new drug and the issues surrounding it.

Marie Smart, Social Worker, The Breckinridge and Christian Care Communities, will join the professors for a panel discussion and question and answer session.

The event is free and open to the public.

The Markesbery Symposium is named in honor and memory of the late Dr. William R. Markesbery, founding Director of the Sanders-Brown Center on Aging and Alzheimer’s Disease Research Center.

Markesbery’s legacy of groundbreaking research has formed the bedrock for our quest to understand and treat Alzheimer’s disesase and to improve the quality of life of the older adults.

For more information, call Hardin Stevens at 859-323-2997.